Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › ascites

Ascites

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for ascites

7 trials tracked for ascites: 3 in phase 3 or 4.

7Trials tracked
3Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Phase 3 1 Phase 2 2 Other / NA 2
  1. Phase 4 Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis Completed
  2. Phase 4 Tolvaptan for Ascites in Cirrhotic Patients Completed
  3. Phase 3 Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites Completed
  4. Phase 2 Treatment With Octreotide in Patients With Lymphangioleiomyomatosis Completed
  5. Phase 2 Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT Completed
  6. N/A Improving Performance of Paracentesis in Medical Residency Training Completed
Show 1 more trials
  1. N/A The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy. Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Refractory ascites significantly reduces social, mental, and physical functioning in patients with advanced chronic liver disease
Gastroenterology Meta-analysis
Refractory ascites significantly reduces social, mental, and physical functioning in patients with advanced chronic liver disease Refractory ascites significantly lowers quality of life for liver patients
This systematic review and meta-analysis of 1040 patients with refractory ascites found significantly lower scores in social functioning (-1…
Living with fluid buildup from advanced liver disease causes significant drops in physical, mental, and social health for both patients and …
Oct 16, 2026
FIPS AUC 0.821 outperforms MELD scores for 90-day mortality prediction in TIPS for ascites
Gastroenterology Meta-analysis
FIPS AUC 0.821 outperforms MELD scores for 90-day mortality prediction in TIPS for ascites New score outperforms MELD for predicting death after TIPS for bleeding
This meta-analysis of 5,180 patients undergoing TIPS for ascites or gastroesophageal bleeding compared MELD-based scores and the FIPS index …
A new scoring system called FIPS may better predict 90-day death risk after TIPS for bleeding than older MELD scores.
Jun 1, 2026
First-in-human study finds VS-01 generally well tolerated in decompensated cirrhosis with ascites
Gastroenterology Phase I
First-in-human study finds VS-01 generally well tolerated in decompensated cirrhosis with ascites Early safety study of VS-01 infusion in 12 patients with advanced liver disease
This phase 1b, open-label, non-randomized study in 12 patients with decompensated cirrhosis, ascites, and covert hepatic encephalopathy foun…
A new liver treatment called VS-01 was safe for patients with advanced disease, causing mostly mild stomach issues in an early study of 12 p…
Apr 9, 2026